LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 93 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,312 | -52.1% | 86,607 | +3.7% | 0.00% | -50.0% |
| Q2 2023 | $265,619 | +34.8% | 83,528 | +0.0% | 0.00% | +100.0% |
| Q1 2023 | $197,079 | -30.6% | 83,508 | +2.0% | 0.00% | -50.0% |
| Q4 2022 | $284,006 | -52.8% | 81,846 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $602,000 | +14.0% | 82,144 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $528,000 | +41.9% | 80,983 | +10.0% | 0.00% | +100.0% |
| Q1 2022 | $372,000 | +283.5% | 73,645 | +486.4% | 0.00% | – |
| Q4 2021 | $97,000 | -49.2% | 12,558 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $191,000 | – | 12,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $156,056,000 | 45.49% |
| Foresite Capital Management IV, LLC | 13,282,181 | $102,804,000 | 21.15% |
| Apoletto Ltd | 15,093,969 | $116,827,000 | 14.55% |
| SB Management Ltd | 3,500,000 | $27,090,000 | 2.68% |
| HSG Holding Ltd | 3,045,997 | $23,576,000 | 2.11% |
| MIC Capital Management UK LLP | 1,320,000 | $10,217,000 | 1.95% |
| Alphabet Inc. | 5,865,125 | $45,396,000 | 1.10% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $12,754,000 | 0.80% |
| Adero Partners, LLC | 491,372 | $3,803,000 | 0.62% |
| Ergoteles LLC | 1,008,428 | $7,805,000 | 0.30% |